Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
3,984,940
Value
$191.0M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,984,940$191.0M<0.1%−580,768−12.7%ReducedHolders
Q1 20264,565,708$167.8M<0.1%−346,183−7.0%ReducedHolders
Q4 20254,911,891$249.9M<0.1%+1,221,675+33.1%AddedHolders
Q3 20253,690,216$204.8M<0.1%+1,833,169+98.7%AddedHolders
Q2 20251,857,047$128.2M<0.1%+424,021+29.6%AddedHolders
Q1 20251,433,026$99.5M<0.1%−43,612−3.0%ReducedHolders
Q4 20241,476,638$127.0M<0.1%+518,914+54.2%AddedHolders
Q3 2024957,724$114.0M<0.1%+43,525+4.8%AddedHolders
Q2 2024914,199$130.5M<0.1%+148,546+19.4%AddedHolders
Q1 2024765,653$98.3M<0.1%+213,486+38.7%AddedHolders
Q4 2023552,167$57.1M<0.1%−75,223−12.0%ReducedHolders
Q3 2023627,390$57.1M<0.1%+143,960+29.8%AddedConverted for a 2-for-1 splitHolders
Q2 2023241,715$39.1M<0.1%−28,008−10.4%ReducedHolders
Q1 2023269,723$42.9M<0.1%−22,371−7.7%ReducedHolders
Q4 2022292,094$39.5M<0.1%−5,477−1.8%ReducedHolders
Q3 2022297,571$29.6M<0.1%+43,848+17.3%AddedHolders
Q2 2022253,723$28.3M<0.1%−64,811−20.3%ReducedHolders
Q1 2022318,534$35.4M<0.1%−14,798−4.4%ReducedHolders
Q4 2021333,332$37.3M<0.1%+4,808+1.5%AddedHolders
Q3 2021328,524$31.5M<0.1%−11,792−3.5%ReducedHolders
Q2 2021340,316$28.5M<0.1%−107,418−24.0%ReducedHolders
Q1 2021447,734$30.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.